newsfilter
← Latest News
ACCESS Newswire·

Cadrenal's Anticoagulation Platform Is Expanding in a $40 Billion Market

PONTE VEDRA, FL / ACCESS Newswire / December 12, 2025 / Cadrenal Therapeutics believes it continues to be misread by the market. Yes, the Company is intentionally narrowly focused. However, the lane it